Clinical Trial Update: Study of HEMAX PFS Versus EPREX/ ERYPO® in Predialysis Chronic Kidney Disease [Phase 3]

View source ↗

Summary

Phase 3 study comparing HEMAX PFS to EPREX/ERYPO in predialysis chronic kidney disease with anemia; trial completed and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease

Drugs mentioned

• EPREX/ERYPO (epoetin alfa)
• HEMAX PFS

Snippet

Sponsor: Bio Sidus SA | Conditions: Anemia of Chronic Kidney Disease | Phase 3 | Status: COMPLETED | Results posted: 2025-03-20